Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on August 19, 2004

Stroke. 2004
Published online before print August 19, 2004, doi: 10.1161/01.STR.0000141160.66818.24
A more recent version of this article appeared on October 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/10/2396    most recent
01.STR.0000141160.66818.24v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malagelada, C.
Right arrow Articles by Rodríguez-Álvarez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malagelada, C.
Right arrow Articles by Rodríguez-Álvarez, J.
Related Collections
Right arrow Animal models of human disease

Submitted on February 27, 2004
Revised on May 6, 2004
Accepted on July 6, 2004

Histamine H2-Receptor Antagonist Ranitidine Protects Against Neural Death Induced by Oxygen-Glucose Deprivation

Cristina Malagelada PhD; Xavier Xifró BSc; Nahuai Badiola BSc; Josefa Sabrià PhD*; and José Rodríguez-Álvarez PhD

From the Institut de Neurociènces and Unitat de Bioquímica de Medicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Spain.

* To whom correspondence should be addressed. E-mail: Josefa.Sabria{at}uab.es.

Background and Purpose--Administration of histamine receptor antagonists has been reported to produce contradictory results, either reducing or increasing neural damage induced by ischemia. In this study, we investigated the neuroprotective effects of histamine H2-receptor antagonists in an "in vitro" model of ischemia.

Methods--Cultured rat brain cortical neurons were exposed to oxygen-glucose deprivation (OGD) in the presence or absence of different histaminergic drugs. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide reduction assay. Necrosis and apoptosis were quantified by staining cells with propidium iodide and Hoechst 33258. Caspase 3 activation was determined by immunocytochemistry and Western blot.

Results--Pretreatment with H2 antagonists effectively reduced neuronal cell death induced by OGD. Ranitidine decreased the number of necrotic and apoptotic cells. Caspase 3 activation and alteration of the neuronal cytoskeleton were also prevented by ranitidine pretreatment. The neuroprotective effect of ranitidine was still evident when added 6 hours after OGD.

Conclusions--H2-receptor antagonists protected against OGD-induced neuronal death. Ranitidine attenuated cell death even when administered after OGD. These data suggest that this drug, which is currently used for the treatment of gastric ulcers, may be useful in promoting recovery after ischemia.


Key words: apoptosis • cerebral ischemia • neuronal death • stroke




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
W. Hamabe, R. Fujita, and H. Ueda
Insulin Receptor-Protein Kinase C-{gamma} Signaling Mediates Inhibition of Hypoxia-Induced Necrosis of Cortical Neurons
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1027 - 1034.
[Abstract] [Full Text] [PDF]